Search for: "Mylan Pharmaceuticals"
Results 241 - 260
of 739
Sort by Relevance
|
Sort by Date
7 Dec 2016, 11:58 pm
Mylan contended that not all forms of pain which fell within the claims contained a central sensitisation component. [read post]
7 Dec 2016, 9:59 pm
Mylan Pharmaceuticals Inc. v. [read post]
20 Nov 2016, 5:17 pm
For example, according to Coffee, the drug pricing scandals that have hit Valeant Pharmaceuticals and Mylan N.V. were the result of compensation schemes that as structured “incentivized” the executives at those companies to take risk. [read post]
18 Nov 2016, 12:44 am
The case also provides a useful comparator for the England and Wales Court of Appeal’s judgment on 13 October 2016 in Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) & Ors [2016] EWCA Civ 1006 (EWCA Judgment) (covered by Brian Cordery of Bristows in ‘Pain and Plausibility – the Lyrica Appeal’), particularly with respect to how Australian and English law determine sufficiency and infringement of Swiss-style claims. [read post]
14 Nov 2016, 2:01 pm
As previously reported, Mylan Inc., the pharmaceutical manufacturer of the life-saving EpiPen, misclassified their brand name drug as generic for years, thus deceiving and effectively defrauding governmentally-funded insurance providers Medicare and Medicaid, resulting in millions of dollars in overpayments by taxpayers, all in an effort to save themselves money prior to hiking the price of The post EpiFail: Gov’t Knew EpiPen Was Misclassified in 2009 appeared first on Legal… [read post]
14 Nov 2016, 9:16 am
Teva Pharmaceuticals USA, Inc., et al. [read post]
18 Oct 2016, 8:23 pm
The petition of the day is: Mylan Pharmaceuticals Inc. v. [read post]
13 Oct 2016, 6:50 am
Lee, No. 16-446 (Eligibility of new use of old manufacture – blackjack game) Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
29 Sep 2016, 9:30 pm
Writing for the New Yorker’s Currency blog, James Surowiecki discussed how he believes the pharmaceutical company Mylan was able to dramatically increase the price of EpiPens, in part by strategically navigating the state and federal regulatory systems. [read post]
28 Sep 2016, 8:39 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Mylan Pharmaceuticals, et al. v. [read post]
21 Sep 2016, 8:54 am
WASHINGTON — The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. [read post]
20 Sep 2016, 4:29 am
| Good news and bad news for bio-pharmaceutical patenting in the United States | HP? [read post]
17 Sep 2016, 10:42 am
What galls us most about Mylan Pharmaceuticals’ inflating the price of the EpiPen to bursting is the stark image it presents of the fix we’re in. [read post]
17 Sep 2016, 4:56 am
| Good news and bad news for bio-pharmaceutical patenting in the United States | HP? [read post]
15 Sep 2016, 4:00 am
Mylan Pharmaceuticals ULC, 2015 FC 125 at paragraph 154, to assist with determining whether a feature was an instruction on how to administer a dosage or an aspect of the dosage form itself for determining whether a claim was patentable subject matter or a method medical treatment. [read post]
9 Sep 2016, 4:15 am
The IPRs, which were filed by American pharmaceutical developer Mylan Inc. [read post]
7 Sep 2016, 5:59 am
[DealBook / New York Times] * Not only is New York Attorney General Eric Schneiderman breathing antitrust accusations down EpiPen-maker Mylan Pharmaceutical's neck, but now a proposed class-action lawsuit has been filed against the company with allegations that its "unconscionable ... price gouging" violated Ohio's consumer protection laws. [read post]
6 Sep 2016, 3:36 pm
The New York Attorney General is investigating whether leading EpiPen Manufacturer, Mylan Pharmaceuticals, violated New York antitrust laws by inserting anticompetitive terms into its EpiPen sales contracts with numerous local school systems. [read post]
6 Sep 2016, 3:30 pm
[Perez Hilton] * EpiPen's maker, Mylan Pharmaceuticals, is in more hot water. [read post]
5 Sep 2016, 1:10 pm
.* My My Mylan: The Trademark Silver Lining for Mylan's EPIPENMylan has recently come under fire for raising the price of the EPIPEN. [read post]
